Does glycated hemoglobin have clinical significance in ischemic stroke patients?
Introduction
It is well known that diabetes may contribute to an increased risk for cardiovascular and cerebrovascular disease including stroke [1], [2]. However, the findings from meta-analyses of the effects of hyperglycemia on stroke are contradictory. While a meta-analysis focusing on prospective cohort studies found that people with chronic hyperglycemia had an increased risk of microvascular complications, such as retinopathy, as well as myocardial infarction and stroke [3], another two meta-analyses and recent randomized controlled trials such as ACCORD, ADVANCE, and VADT found that lowering blood glucose did not significantly reduce the pooled incidence of stroke [4], [5], [6], [7], [8].
The HbA1c level reflects long-term glycemic control and is a more accurate and stable measure than fasting blood glucose levels; therefore, it is widely used in clinical practice to assess control of diabetes [9]. Observational analyses of data from the United Kingdom Prospective Diabetes Study (UKPDS) suggested HbA1c is positively associated with stroke risk [10], and a cohort study revealed that elevated HbA1c could be an independent risk factor for ischemic stroke in people with and without diabetes [11]. Furthermore, it was reported that HbA1c was independently associated with cerebral microbleeds in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [12]. The relationship between cerebral microbleeds and diabetes, however, has been unclear [13]. We wondered whether glycated hemoglobin might influence microbleeds in only a specific disease group, such as CADASIL, or if it might be related to general ischemic stroke.
In the present study, we examined whether HbA1c had any clinical significance associated with ischemic stroke and whether it could be an independent risk factor of vascular lesions in the brain.
Section snippets
Subjects
From October, 2002, to March, 2006, we first collected 849 consecutive ischemic stroke patients who visited the department in our hospital (less than 7 days after onset). We excluded patients whose stroke mechanism was cardioembolism (n = 170) or other determined etiologies (n = 10). HbA1c was examined on admission, and patients were excluded if they did not have laboratory data for HbA1c (n = 30). Therefore, the final study population consisted of a total of 639 patients.
This study was approved by
Results
Of the 639 subjects included in this study, 438 were male (68.5%) and the mean age of the patients was 64.9 ± 11.1 years. There were 448 patients with hypertension (70.1%), 247 with diabetes (38.7%), 300 with dyslipidemia (46.9%), and 259 with a smoking history (40.5%). We divided subjects into two groups depending on the presence of diabetes (Table 1). Previous stroke history, increased FG and HbA1c level, dyslipidemia, and reduced high density lipoprotein (HDL) level were more common in the
Discussion
We found that HbA1c was not independently associated with any of the examined types of cerebrovascular lesions in ischemic stroke patients with and without diabetes. In our study, age was the most important risk factor for LAD; while male gender, hypertension, and dyslipidemia showed tendencies towards a relationship with LAD. In addition, age and hypertension were significantly related with a risk of leukoaraiosis. These results were similar to previous studies demonstrating differences in
Competing interests
None.
Acknowledgements
This study was supported by grants of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (A060171).
References (43)
- et al.
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus
Am J Med
(2001) - et al.
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Lancet
(2009) - et al.
Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study
Lancet Neurol
(2005) Effect of age on the percentage of hemoglobin A1c and the percentage of total glycohemoglobin in non-diabetic persons
J Lab Clin Med
(1999)- et al.
HbA1C and serum fructosamine in diabetic patients: relationship to age, clotting and fibrinolysis parameters and urinary microalbumin excretion
Clin Chim Acta
(1991) - et al.
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women
Am J Med
(2007) - et al.
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study
J Clin Epidemiol
(1996) - et al.
A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women
Arch Intern Med
(1991) - et al.
The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up
Arch Intern Med
(2004) - et al.
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
Ann Intern Med
(2004)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
N Engl J Med
Effects of intensive glucose lowering in type 2 diabetes
N Engl J Med
Glucose control and vascular complications in veterans with type 2 diabetes
N Engl J Med
Tests of glycemia in diabetes
Diabetes Care
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
BMJ
Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study
Brain
Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting
Brain
The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes
Diabetes Care
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, valuation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
Circulation
Cerebral microbleeds are regionally associated with intracerebral hemorrhage
Neurology
Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people
Stroke; J Cereb Circ
Cited by (15)
Glycosylated Hemoglobin and Functional Outcome after Acute Ischemic Stroke
2016, Journal of Stroke and Cerebrovascular DiseasesCitation Excerpt :The elevated HbA1c levels could be also a cue of careless attitude toward a healthy lifestyle and poor adherence to treatment of coexisting vascular risk factors and associated medical conditions which could in turn negatively influence patients' outcome. The absence of meaningful differences in the rates of suboptimal glycemic control across the different stroke etiologies confirmed previous evidence of similar incidences of large- and small-artery diseases regardless of the HbA1c levels.27 Additionally, the independence of the association between the HbA1c status and the functional outcome from the stroke subtype further suggests the role of the long-term angiopathic changes induced by chronic impairment of glycemic control in influencing the recovery and explains the prognostic value of the HbA1c insofar as marker of long-standing abnormally high glycemia.
Sex Differences in the Association between Hemoglobin A1c and Cerebral White Matter Lesions in the General Japanese Population
2023, Acta Neurologica ScandinavicaAssociation between haemoglobin A1c and cerebral microbleeds in community-based stroke-free individuals: A cross-sectional study
2022, Diabetes/Metabolism Research and ReviewsHydration prevents chronic hyperglycaemic patients from neurological deterioration post-ischaemic stroke
2018, Acta Neurologica Scandinavica